Study of the prevalence of metabolic syndrome among patients with polycystic ovary syndrome at Tishreen University Hospital

Authors

  • Yara jadid Tishreen University
  • Areej Bobo Tishreen University
  • Maysoon Diop Tishreen University

Abstract

Background: Polycystic ovary syndrome (PCOS) is one of the most common endocrine disorders with 7-15% prevalence that affects women of reproductive age. Polycystic ovary syndrome (PCOS) and the metabolic syndrome have many features in common and may share the same pathogenesis. Recent studies have reported varied prevalence of metabolic syndrome (MetS) in women with PCOS.

 

Objectives: The aim of the present study was to evaluate the prevalence of metabolic syndrome in women with polycystic ovary syndrome (PCOS).

Methods and patients: All the women attending the endocrine clinic categorized as polycystic ovary syndrome according to Rotterdam criteria during the study period were included in the study. The women with PCOS underwent screening for metabolic syndrome as defined by the modified American Heart Association/ National Heart Lung Blood Institute (AHA/NHLBI) ATP 111 definition. A multivariate logistic regression analysis was applied and significant predictors identified for the prediction of metabolic syndrome.

 

Results: The overall prevalence of metabolic syndrome according to the AHA/NHLBI ATP III criteria was 32.8%.The prevalence for individual components comprising the metabolic syndrome were :waist circumference greater than 88 cm in 56.6%, high-density lipoprotein cholesterol less than 50 mg/dl in 41.6%, triglycerides greater than or equal to 150 mg/dl in 33.8%, fasting glucose concentrations greater than or equal to 100 mg/dl in 13.8%,and  blood pressure greater than or equal to 130/85 mm Hg in 12.8%.

 

Conclusions: The metabolic syndrome and its individual components are common in PCOS, particularly among women with the central obesity.

Downloads

Published

2024-09-02

How to Cite

1.
جديد ي, أريج بوبو, ميسون ديوب. Study of the prevalence of metabolic syndrome among patients with polycystic ovary syndrome at Tishreen University Hospital. Tuj-hlth [Internet]. 2024Sep.2 [cited 2024Nov.24];46(3):675-91. Available from: https://journal.tishreen.edu.sy/index.php/hlthscnc/article/view/17455

Issue

Vol. 46 No. 3 (2024): Tishreen University Journal for Research and Scientific Studies - Health Sciences Series

Section

Master student researches

License

Creative Commons License

This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.

The authors retain the copyright and grant the right to publish in the magazine for the first time with the transfer of the commercial right to Tishreen University Journal for Research and Scientific Studies - Health Sciences Series

 Under a CC BY- NC-SA 04 license that allows others to share the work with of the work's authorship and initial publication in this journal. Authors can use a copy of their articles in their scientific activity, and on their scientific websites, provided that the place of publication is indicted in  Tishreen University Journal for Research and Scientific Studies - Health Sciences Series   .  The Readers have the right to send, print and subscribe to the initial version of the article, and the title of  Tishreen University Journal for Research and Scientific Studies - Health Sciences Series  Publisher

journal uses a CC BY-NC-SA license which mean

You are free to:

  • Adapt — remix, transform, and build upon the material
  •  
  • The licensor cannot revoke these freedoms as long as you follow the license terms.

 

  • Attribution — You must give appropriate credit, provide a link to the license, and indicate if changes were made. You may do so in any reasonable manner, but not in any way that suggests the licensor endorses you or your use.
  • NonCommercial — You may not use the material for commercial purposes.
  • ShareAlike — If you remix, transform, or build upon the material, you must distribute your contributions under the same license as the original.
  • No additional restrictions — You may not apply legal terms or technological measures that legally restrict others from doing anything the license permits.